Evidence map›Paper›PMID 25809267›Full record

ArticleBiophysical journal2015

Structural studies of truncated forms of the prion protein PrP.

William Wan, Holger Wille, Jan Stöhr, Amy Kendall, Wen Bian, Michele McDonald, Sarah Tiggelaar, Joel C Watts, Stanley B Prusiner, Gerald Stubbs

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The Structure of PrPPathogens (Basel, Switzerland) · 2018
    Review
  13. Structural Biology of PrP Prions.Cold Spring Harbor perspectives in medicine · 2017
    Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

William WanDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee.
Holger WilleInstitute for Neurodegenerative Diseases and Department of Neurology, University of California, San Francisco, San Francisco, California.
Jan StöhrInstitute for Neurodegenerative Diseases and Department of Neurology, University of California, San Francisco, San Francisco, California.
Amy KendallDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee.
Wen BianDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee.
Michele McDonaldDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee.
Sarah TiggelaarDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee.
Joel C WattsInstitute for Neurodegenerative Diseases and Department of Neurology, University of California, San Francisco, San Francisco, California.
Stanley B PrusinerInstitute for Neurodegenerative Diseases and Department of Neurology, University of California, San Francisco, San Francisco, California.
Gerald StubbsDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee. Electronic address: gerald.stubbs@vanderbilt.edu.
Vanderbilt University · USUniversity of California, San Francisco · USInstitute for Neurodegenerative Disorders · US

Funding

VIRAL DEGENERATIVE DEMENTING DISEASE IN AGING (SUPP)P01AG002132 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHNIER, PAUL · 1985 to 2024
$51.7M
UNDERSTANDING AND IMPROVING SMALL MOLECULE INHIBITORS OF PRION REPLICATIONP01AG021601 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRUSINER, STANLEY B · 2003 to 2013
$31.9M
SYNTHETIC AND RECOMBINANT PRP PEPTIDES AND PROTEINSP01AG010770 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRUSINER, STANLEY B · 1993 to 2015
$30.3M
Time resolved SAXS studies on the RP2/Arl3 complex pp.484-485P41GM103622 · NIGMS · ILLINOIS INSTITUTE OF TECHNOLOGY · PI IRVING, THOMAS C · 2012 to 2020
$11.9M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Towards Therapeutics for Neurodegenerative DiseasesR37AG031220 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRUSINER, STANLEY B · 2008 to 2017
$6.2M
Structure and assembly of the fungal prion HET-sF31AG040947 · NIA · VANDERBILT UNIVERSITY · PI WAN, WILLIAM N · 2011 to 2013
$68k
NIA NIH HHS AG002132NIA NIH HHS AG010770NIA NIH HHS AG021601NIA NIH HHS F31 AG040947NIA NIH HHS F31-AG040947NIA NIH HHS P01 AG002132NIA NIH HHS P01 AG010770NIA NIH HHS P01 AG021601NIA NIH HHS R37 AG031220NIGMS NIH HHS 9 P41 GM103622NIGMS NIH HHS P41 GM103622NIGMS NIH HHS T32 GM008320
6 · The paper itself

Abstract

Prions are proteins that adopt self-propagating aberrant folds. The self-propagating properties of prions are a direct consequence of their distinct structures, making the understanding of these structures and their biophysical interactions fundamental to understanding prions and their related diseases. The insolubility and inherent disorder of prions have made their structures difficult to study, particularly in the case of the infectious form of the mammalian prion protein PrP. Many investigators have therefore preferred to work with peptide fragments of PrP, suggesting that these peptides might serve as structural and functional models for biologically active prions. We have used x-ray fiber diffraction to compare a series of different-sized fragments of PrP, to determine the structural commonalities among the fragments and the biologically active, self-propagating prions. Although all of the peptides studied adopted amyloid conformations, only the larger fragments demonstrated a degree of structural complexity approaching that of PrP. Even these larger fragments did not adopt the prion structure itself with detailed fidelity, and in some cases their structures were radically different from that of pathogenic PrP(Sc).

Indexed as

AmyloidAnimalsBrainEscherichia coliGPI-Linked ProteinsHumansMiceMice, TransgenicMicroscopy, ElectronNerve Tissue ProteinsPrionsProtein ConformationRecombinant ProteinsX-Ray DiffractionAmyloidGPI-Linked ProteinsNerve Tissue ProteinsPrionsRecombinant ProteinsSPRN protein, humanSprn protein, mouse

Identifiers

PMID25809267
PMCPMC4375555
OpenAlexW2016458412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.